PharmaDrug (OTC: LMLLF) Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer
Patent claims on synergistic application of cepharanthine, cabazitaxel and other taxane family members used in combination to treat primary, metastatic and chemotherapy-resistant prostate cancer Expands on Company’s ‘pipeline in a pill’ strategy with cepharanthine in […]
